A long-awaited oral multiple sclerosis drug from Merck KGaA was among a raft of medicines given the green light by Europe's regulator on Friday. Europe’s CHMP top scientific committee gave a ...

In data presented at last year’s ASCO congress, vorasidenib was shown to reduce disease progression and death in grade 2 gliomas with IDH mutations compared to placebo and to delay the need for ...

UPDATE (March 10, 2025): Google still hopes Trump will provide help, so that it doesn’t have to sell Chrome. DOJ, on the flip side, still wants Google to follow through. Read more about the ...

Now? A few murmurs of concern, but no real fight. Or challenges to agencies like Natural England with a review of environmental regulators through an economic lens which, under the Tories, would have ...